PT  - JOURNAL ARTICLE
AU  - Ganz, Andrea B.
AU  - Zhang, Meng
AU  - Koopmans, Frank
AU  - Li, Ka Wan
AU  - Miedema, Suzanne S.M.
AU  - Rozemuller, Annemieke J.M.
AU  - Hulsman, Marc
AU  - ,
AU  - Scheltens, Philip
AU  - Hoozemans, Jeroen J.M.
AU  - Reinders, Marcel J.T.
AU  - Smit, August B.
AU  - Holstege, Henne
TI  - Proteomic profiling of aging brains identifies key proteins by which cognitively healthy centenarians defy their age by decades
AID  - 10.1101/2023.11.30.23299224
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.11.30.23299224
4099  - http://medrxiv.org/content/early/2023/11/30/2023.11.30.23299224.short
4100  - http://medrxiv.org/content/early/2023/11/30/2023.11.30.23299224.full
AB  - Some individuals reach extreme ages without any signs of cognitive decline. Here, we show that based on key proteins, cognitively healthy centenarians have a biologically younger brain. We compared the brain proteomic signatures of 58 self-reported cognitively healthy centenarians with 61 non-demented individuals and 91 AD patients. The abundance of 472 proteins strongly associated with AD Braak stages of which 64 were differentially regulated in centenarians. With increasing Braak stages, the abundance of toxic peptides of MAPT increased in AD patients, while these remained low in centenarians. Furthermore, the abundance of 174 proteins strongly changed with age, of which 108 were differentially regulated in centenarians. In fact, in brains from centenarians the abundances of essential proteins were representative of brains from individuals who were a median 18- and up to 28-years ‘younger’. The proteins involved represent diverse cellular processes, and suggest that maintained protein homeostasis is central in maintaining brain-health.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo Applicable Funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Medical Ethics Committee of the Amsterdam UMC gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.